Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
5
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
ipo
national
cancer
chronic kidney disease
crispr
glaxosmithkline
medical devices
medicare
messenger rna
parkinson's disease
san francisco
2025
What
therapeutics
5
×
million
bio
cancer
companies
drug
immunotherapy
ipo
life
new
roundup
science
sciences
week
adding
agency
aimmune
allergy
allogene
approval
approved
awarded
bets
biotechs
black
boost
club
continue
continued
crispr
crop
debut
developed
diamond
diamond’s
diversity
exceeded
expensive
far
fda
Language
unset
Current search:
therapeutics
×
" seattle top stories "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M